Renal function and the rate of disappearance of methotrexate from serum
- 1 January 1975
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 8 (6) , 439-444
- https://doi.org/10.1007/bf00562319
Abstract
The disappearance of methotrexate (MTX) from serum was studied using H3-MTX. The overall elimination half-life (MTX T 1/2) was well defined from one to about six hours after i.v. administration; in 25 patients it ranged from 102 min to 750 min and was inversely related to endogenous creatinine clearance, which ranged from 6 to 140 ml/min. The corresponding apparent volume of distribution, V, obtained by extrapolation tended to decrease at lower levels of renal function. The total clearance of MTX calculated in this period varied linearly with creatinine clearance. In patients with normal serum creatinine concentration, the half-life increased with advancing age, which reflects the concurrent age-dependent decrease in creatinine production and renal function. This illustrates the need for knowledge of renal function, not based solely on serum creatinine concentration, in patients treated with methotrexate or other drugs eliminated by the kidneys. In 9 patients the results were not affected by treatment with diuretics (furosemide, hydroflumethiazide). In four patients serum MTX concentration was measured for up to 24–72 hours. An increasing half-life of MTX with time was found, suggesting that the elimination kinetics of the drug would be most adequately described by a multi-compartment model.Keywords
This publication has 20 references indexed in Scilit:
- Psoriasis-Liver-Methotrexate InteractionsArchives of Dermatology, 1973
- RAPID EVALUATION OF CREATININE CLEARANCEThe Lancet, 1971
- Multiple Dose Kinetics and Drug Dosage in Patients with Kidney DiseaseActa Pharmacologica et Toxicologica, 1971
- Liver Damage due to Methotrexate in Patients with PsoriasisBMJ, 1971
- Blood Levels of Methotrexate and the Treatment of PsoriasisArchives of Dermatology, 1971
- Methotrexate for PsoriasisArchives of Dermatology, 1971
- THE INFLUENCE OF PHENOBARBITAL ON THE HALF‐LIFE OF DIPHENYLHYDANTOIN IN MANActa Medica Scandinavica, 1969
- A Guide to Use of Antibiotics in Patients with Renal DiseaseAnnals of Internal Medicine, 1967
- Effect of Methotrexate Therapy upon Choriocarcinoma and ChorioadenomaExperimental Biology and Medicine, 1956
- Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)New England Journal of Medicine, 1948